The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
about
[Novel molecular aspects of chordomas].Novel targeted therapies in chordoma: an update.Chordoma: an update on the pathophysiology and molecular mechanismsGlycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Targeting PD-1/PD-L1 in lung cancer: current perspectives.A critical question for cancer therapy: what new targets exist?High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity.BTNET : boosted tree based gene regulatory network inference algorithm using time-course measurement data.ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia-Reperfusion Injury.A giant lumbar chordoma: A case report.
P2860
Q33275430-2F0645C9-1026-4748-BCA2-78ECE42AA6C4Q33275653-6AF30ABE-3AF3-4CD0-88A0-627E93C10CD7Q33275783-D02D30F9-DB69-4AAB-B352-82F3DE801CB4Q35961610-9D5F6351-5694-4A3B-852C-6409B6E50B56Q37687515-8B39957B-5DE8-4DF9-B6A5-042EDFAC8E1DQ37699384-E0509E05-F8F2-418B-988D-7FE0A013D07DQ38238094-D9BFF3CC-B784-439A-9100-0A0063DC374CQ38956294-E47816A7-515B-4324-9BE2-541653F387EAQ41940514-7028389C-D186-4D75-A339-250C4F447FB1Q41969924-B4680936-F5DA-4027-83D2-476B686355D8Q42260320-72F62427-ECAF-46D5-A7AF-0CCA00BA1DBBQ50128933-C9E85514-DA83-4F93-8CDD-A0A119750301Q52645544-F684B2E5-F2FA-417D-997F-2EA5F8C9BC48Q55437977-C3FD684F-FDF9-4C01-A979-C663067BA82BQ55514723-298B77FB-5E4D-43E6-9D16-71CFD461A2D8
P2860
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@ast
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@en
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@nl
type
label
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@ast
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@en
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@nl
prefLabel
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@ast
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@en
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@nl
P2093
P2860
P356
P1433
P1476
The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
@en
P2093
Sagar R Shah
Wesley Hsu
Yunping Hu
P2860
P304
P356
10.1093/CARCIN/BGU014
P407
P577
2014-01-20T00:00:00Z